DexCom, Inc.
DXCM
Ранг среди акций
#759
DexCom, Inc. is a medical technology company primarily focused on innovating,... DexCom, Inc. is a medical technology company primarily focused on innovating, developing, and marketing continuous glucose monitoring (CGM) systems. Operating across the United States and internationally, the firm provides its solutions for individuals managing diabetes as well as for healthcare practitioners. Its product portfolio features the DexCom G6, a comprehensive CGM system for diabetes management; the Dexcom Real-Time API, enabling authorized third-party developers to integrate live CGM data into their digital health applications; the Dexcom ONE, which aims to supersede traditional finger-prick blood glucose testing for treatment decisions; and Dexcom Share, a remote monitoring platform. The company is also developing the Dexcom G7, its next-generation CGM system. Furthermore, DexCom, Inc. has a licensing and collaboration agreement with Verily Life Sciences LLC and Verily Ireland Limited to advance blood-based or interstitial glucose monitoring products. The company directly sells its offerings to specialists such as endocrinologists, physicians, and diabetes educators. DexCom, Inc. was founded in 1999 and maintains its headquarters in San Diego, California.
Цена акции
$85.72
Последняя синхронизация: 2026-10-20
Рыночная капитализация
$32.35B
Изменение (1 день)
-0.30%
Изменение (1 год)
22.90%
Страна
US
Торговля DexCom, Inc. (DXCM)
Категория
Healthcare
Коэффициент P/S для DexCom, Inc. (DXCM)
Коэффициент P/S на October 2026 TTM: 6.34
Согласно последним финансовым отчетам и цене акций DexCom, Inc., текущий коэффициент P/S (TTM) составляет 6.34. В конце 2023 он составлял 13.22.
История P/S для DexCom, Inc. с 2000 по 2026
Коэффициент P/S в конце каждого года
| Год | P/S | Изменить |
|---|---|---|
| 2026 (TTM) | 6.34 | -18.73% |
| 2024 | 7.80 | -40.99% |
| 2023 | 13.22 | -12.74% |
| 2022 | 15.15 | -28.56% |
| 2021 | 21.21 | 17.10% |
| 2020 | 18.11 | 34.16% |
| 2019 | 13.50 | 31.82% |
| 2018 | 10.24 | 48.57% |
| 2017 | 6.89 | -20.83% |
| 2016 | 8.71 | -46.45% |
| 2015 | 16.26 | 1.84% |
| 2014 | 15.97 | 1.51% |
| 2013 | 15.73 | 68.20% |
| 2012 | 9.35 | 16.67% |
| 2011 | 8.02 | -49.77% |
| 2010 | 15.96 | 32.25% |
| 2009 | 12.07 | 45.88% |
| 2008 | 8.27 | -84.71% |
| 2007 | 54.09 | -56.38% |
| 2006 | 124.02 | 0.00% |
| 2005 | 0.00 | 0.00% |
| 2004 | 0.00 | 0.00% |
| 2003 | 0.00 | 0.00% |
| 2002 | 0.00 | 0.00% |
| 2001 | 0.00 | 0.00% |
| 2000 | 0.00 | 0.00% |
Коэффициент P/S для аналогичных компаний или конкурентов
| Компания | P/S | Разница P/S | Страна |
|---|---|---|---|
| 3.82 | -39.66% |
US
|
|
| 2.78 | -56.07% |
IE
|
|
| 4.18 | -34.08% |
US
|
|
| 2.97 | -53.14% |
US
|
|
| - | - |
DE
|
